Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle

By Aspden K.   Dijk A.A.v.   Bingham J.   Cox D.   Passmore J.-A.   Williamson A.-L.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2693-2701

Elsevier

Access to resources Recommend Favorite

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

By Fries L.F.   Tartaglia J.   Taylor J.   Kauffman E.K.   Meignier B.   Paoletti E.   Plotkin S.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 428-434

Elsevier

Access to resources Recommend Favorite

Influence of live respiratory syncytial virus priming on the immune response generated by a recombinant vaccine candidate, BBG2Na

By Goestch L.   Plotnicky-Gilquin H.   Champion T.   Beck A.   Haeuw J.F.   Nguyen T.   Bonnefoy J.Y.   Corvaa N.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2648-2655

Elsevier

Access to resources Recommend Favorite

Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies

By Tims T.   Briggs D.J.   Davis R.D.   Moore S.M.   Xiang Z.   Ertl H.C.J.   Fu Z.F.  

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2804-2807

Elsevier

Access to resources Recommend Favorite

Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates

By Jin H.   Cheng X.   Traina-Dorge V.L.   Park H.J.   Zhou H.   Soike K.   Kemble G.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3647-3652

Elsevier

Access to resources Recommend Favorite